Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ProfoundBio

Request full access

An oncology biotherapeutics company

Woodinville, United StatesFounded 2018Biotech & Life Sciences

About ProfoundBio

ProfoundBio is a clinical-stage biotherapeutics startup that operates in the oncology sector. The company is dedicated to the discovery and development of novel antibody-based therapeutic agents, with a primary focus on treating a wide range of cancers. Their proprietary technology platform, which is based on Antibody-Drug Conjugates (ADCs), is at the forefront of their research and development efforts. ADCs are a type of targeted cancer therapy that delivers cytotoxic drugs directly to cancer cells, thereby minimizing damage to healthy cells.

The company's business model revolves around the development of these novel therapies and their subsequent commercialization. ProfoundBio's revenue generation strategy is likely to be based on the sales of these therapies once they have been approved by regulatory bodies such as the FDA.

ProfoundBio's clients are primarily patients suffering from various types of cancer. The company aims to provide these patients with innovative and effective treatments that have the potential to cure their disease.

The company's team comprises experienced scientists and clinicians who adopt a creative approach to drug discovery and development. They are committed to rapidly bringing their novel therapies to patients, which could potentially give ProfoundBio a competitive edge in the fast-paced biotech industry.

Source: Dealroom company data

ProfoundBio in the Woodinville ecosystem

Live from Dealroom

The ProfoundBio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

33 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A18 investors entered at this stage

Series B and later12 investors entered at this stage

Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$513k

8 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See ProfoundBio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.